KNL1 and brain neoplasm: In conclusion, inhibition of KNL1, CENPE, ASPM, CITK, and KIF14 may mimic the effects of MTAs on cell division but could work with particular effectiveness on brain tumor cells, underscoring the importance of developing specific inhibitors and test them in clinical trials.